Research progress in the imaging diagnosis of non-alcoholic fatty pancreas disease
Author information
Zhao-Chun Chi. Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, 266011, China
Correspondence to: Zhao-Chun Chi, Zhao-Chun Chi. Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong, 266011, China. E-mail:
c.z.chow@163.com
Abstract
Currently, imaging modalities such as ultrasonography, magnetic resonance imaging (MRI), and computed tomography (CT) are considered the method of choice for diagnosing non-alcoholic fatty pancreas disease. In addition, imaging-based clinical examination methods such as B-scan ultrasonography, transient elastography, and MRI-proton density fat fraction are the most widely used and have a high diagnostic value. Endoscopic ultrasonography is more accurate than CT and MRI in diagnosing pancreatic steatosis. MRI is a sensitive, non-invasive, and safe inspection method and also the best imaging technique to assess pancreatic steatosis. However, no clear consensus has been reached on diagnostic methodology for pancreatic fat.
Keywords
non-alcoholic fatty pancreatic disease,
imaging diagnosis
|
Copyright © 2025 Authors.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
|
About this Article
Cite this article
|
Chi ZC. Research progress in the imaging diagnosis of non-alcoholic fatty pancreas disease. Gastroenterol & Hepatol Res. 2021;3(1):4. doi: 10.53388/ghr2021-03-030.
|
| Copied to clipboard
|
Copy
Export to RIS
Export to EndNote
|
|
Citation copied!
|
Article History
| Received |
Revised |
Accepted |
Published |
|
|
|
|
March 12, 2021
|
DOI
http://dx.doi.org/10.53388/ghr2021-03-030
-
Gastroenterology & Hepatology Research
-
-
eISSN 2703-173X